{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:54:52Z","timestamp":1788501292063,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.str.2024.07.014","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:40:31Z","timestamp":1723646431000},"page":"1404-1418.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-8037","authenticated-orcid":false,"given":"Tulika","family":"Tulika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulgencio","family":"Ruso-Julve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ljungars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Rivera-de-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Fern\u00e1ndez-Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma B.","family":"Belfakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina M.S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Boyens-Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Buell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri A.","family":"Sakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer V.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus-Frederik","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Ledsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn G.","family":"Voldborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Schlothauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Terje","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-5574","authenticated-orcid":false,"given":"Andreas H.","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2024.07.014_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2014296","article-title":"Antibodies to watch in 2022","volume":"14","author":"Kaplon","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the \u201chigh-hanging fruit.\u201d","volume":"17","author":"Carter","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2024.07.014_bib3","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.cell.2022.05.029","article-title":"Designing antibodies as therapeutics","volume":"185","author":"Carter","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.str.2024.07.014_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of\u00a0diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.str.2024.07.014_bib5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tips.2018.07.007","article-title":"Targeting FcRn to generate antibody-based therapeutics","volume":"39","author":"Ward","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.str.2024.07.014_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01540","article-title":"The neonatal Fc receptor (FcRn): A misnomer?","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal Fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib8","first-page":"249","article-title":"FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions","volume":"382","author":"Challa","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1600-0854.2009.00887.x","article-title":"Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery","volume":"10","author":"Gan","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.str.2024.07.014_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tcb.2004.11.004","article-title":"A passionate kiss, then run: exocytosis and recycling of IgG by FcRn","volume":"15","author":"Lencer","year":"2005","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.str.2024.07.014_bib11","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1091\/mbc.e04-08-0735","article-title":"From sorting endosomes to exocytosis: association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling","volume":"16","author":"Ward","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.str.2024.07.014_bib12","first-page":"1","article-title":"Boosting therapeutic potency of antibodies by taming Fc domain functions","volume":"51","author":"Kang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.str.2024.07.014_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12392","article-title":"Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation","volume":"270","author":"Igawa","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.str.2024.07.014_bib14","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1038\/s41467-019-13108-2","article-title":"An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2024.07.014_bib15","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.4049\/jimmunol.169.9.5171","article-title":"Increasing the affinity of a human IgG1 for the neonatal Fc receptor: Biological consequences","volume":"169","author":"Dall'Acqua","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nbt.1601","article-title":"Enhanced antibody half-life improves in\u00a0vivo activity","volume":"28","author":"Zalevsky","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.str.2024.07.014_bib17","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall\u2019Acqua","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2024.07.014_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01714-16","article-title":"Safety, tolerability, and pharmacokinetics of MEDI8897, the respiratory syncytial virus prefusion F-targeting monoclonal antibody with an extended half-life, in healthy adults","volume":"61","author":"Griffin","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.str.2024.07.014_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03787-x","article-title":"Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn, and plasma half-life","volume":"5","author":"Gj\u00f8lberg","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.str.2024.07.014_bib20","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.1408766112","article-title":"Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics","volume":"112","author":"Schoch","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.str.2024.07.014_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/19420862.2015.1016696","article-title":"Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics","volume":"7","author":"Datta-Mannan","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib22","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1091\/mbc.e13-04-0174","article-title":"Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules","volume":"24","author":"Weflen","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.str.2024.07.014_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nbt.1691","article-title":"Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization","volume":"28","author":"Igawa","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.str.2024.07.014_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12929-021-00709-7","article-title":"pH-responsive antibodies for therapeutic applications","volume":"28","author":"Klaus","year":"2021","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.str.2024.07.014_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/19420862.2015.1006993","article-title":"De novo isolation of antibodies with pH-dependent binding properties","volume":"7","author":"Bonvin","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/19420862.2014.985993","article-title":"A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display","volume":"7","author":"Schr\u00f6ter","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib27","doi-asserted-by":"crossref","first-page":"11090","DOI":"10.1074\/jbc.M111.319764","article-title":"Increasing serum half-life and extending cholesterol lowering in\u00a0vivo by engineering antibody with pH-sensitive binding to PCSK9","volume":"287","author":"Chaparro-Riggers","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2024.07.014_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4161\/mabs.26389","article-title":"The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics","volume":"5","author":"Devanaboyina","year":"2013","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063236","article-title":"Engineered monoclonal antibody with novel antigen-sweeping activity in\u00a0vivo","volume":"8","author":"Igawa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2024.07.014_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.str.2024.07.014_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195909","article-title":"Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action","volume":"13","author":"Sheridan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2024.07.014_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209509","article-title":"Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody","volume":"13","author":"Sampei","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2024.07.014_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2068213","article-title":"Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering","volume":"14","author":"Hori","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41587-019-0073-7","article-title":"Engineering a HER2-specific antibody-drug conjugate to increase lysosomal delivery and therapeutic efficacy","volume":"37","author":"Kang","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.str.2024.07.014_bib35","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2020.08.028","article-title":"ARGX-117, a therapeutic complement inhibiting antibody targeting C2","volume":"147","author":"Van de Walle","year":"2021","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/19420862.2018.1545510","article-title":"Engineered pH-dependent recycling antibodies enhance elimination of Staphylococcal enterotoxin B superantigen in mice","volume":"11","author":"Kroetsch","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17460441.2019.1646723","article-title":"How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?","volume":"14","author":"Laustsen","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.str.2024.07.014_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4821","article-title":"Phage display assisted discovery of a pH-dependent anti-\u03b1-cobratoxin antibody from a natural variable domain library","volume":"32","author":"Tulika","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.str.2024.07.014_bib39","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1021\/bi00045a005","article-title":"Analysis of the pH dependence of the neonatal Fc receptor\/immunoglobulin G interaction using antibody and receptor variants","volume":"34","author":"Raghavan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.str.2024.07.014_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0167-4838(83)90276-5","article-title":"1H-NMR study on the tautomerism of the imidazole ring of histidine residues. I. Microscopic pK values and molar ratios of tautomers in histidine-containing peptides","volume":"742","author":"Tanokura","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.str.2024.07.014_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2143009","article-title":"Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice","volume":"14","author":"Egli","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib42","doi-asserted-by":"crossref","unstructured":"W.R. Strohl, and L.M. Strohl, eds. (2012). Chapter 16-Development issues:\u00a0antibody stability, developability, immunogenicity, and comparability. Therapeutic Antibody Engineering Woodhead Publishing Series in Biomedicine. (Woodhead Publishing), pp. 377\u2013595. https:\/\/doi.org\/10.1533\/9781908818096.377.","DOI":"10.1533\/9781908818096.377"},{"key":"10.1016\/j.str.2024.07.014_bib43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41570-022-00438-x","article-title":"Non-specificity as the sticky problem in therapeutic antibody development","volume":"6","author":"Ausserw\u00f6ger","year":"2022","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.str.2024.07.014_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41467-023-42624-5","article-title":"Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper","volume":"15","author":"S\u00f8rensen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2024.07.014_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2024.07.014_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxicon.2015.03.001","article-title":"Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins","volume":"99","author":"Laustsen","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.str.2024.07.014_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107024","article-title":"Lys49 myotoxins, secreted phospholipase A2-like proteins of viperid venoms: A comprehensive review.","volume":"224","author":"Lomonte","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.str.2024.07.014_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0014-2999(90)94190-9","article-title":"alpha-Cobratoxin blocks the nicotinic acetylcholine receptor in rat hippocampal neurons","volume":"191","author":"Alkondon","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.str.2024.07.014_bib49","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.7717\/peerj.569","article-title":"Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?","volume":"2","author":"Mora-Obando","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.str.2024.07.014_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0041-0101(89)90039-1","article-title":"A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo).","volume":"27","author":"Lomonte","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.str.2024.07.014_bib51","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1186\/gb-2007-8-11-r254","article-title":"Application of phage display to high throughput antibody generation and characterization","volume":"8","author":"Schofield","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.str.2024.07.014_bib52","series-title":"Engineering and Structural Characterization of Cross-Reactive, pH-Sensitive Antibodies against the Long-Chain \u03b1-neurotoxins","author":"Wade","year":"2023"},{"key":"10.1016\/j.str.2024.07.014_bib53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41467-018-03061-x","article-title":"A human endothelial cell-based recycling assay for screening of FcRn targeted molecules","volume":"9","author":"Grevys","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2024.07.014_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103746","article-title":"Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life","volume":"25","author":"Grevys","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.str.2024.07.014_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00249-023-01658-9","article-title":"SDS-induced hexameric oligomerization of myotoxin-II from Bothrops asper assessed by sedimentation velocity and nuclear magnetic resonance","volume":"52","author":"Henrickson","year":"2023","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.str.2024.07.014_bib56","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1074\/jbc.M111.322313","article-title":"Dimeric \u03b1-Cobratoxin X-ray Structure: location of intermolecular disulfides and possible mode of binding to nicotinic acetylcholine receptors","volume":"287","author":"Osipov","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2024.07.014_bib57","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2171248","article-title":"Assessing developability early in the discovery process for novel biologics","volume":"15","author":"Fern\u00e1ndez-Quintero","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223802","article-title":"Specific attributes of the VL domain influence both the structure and structural variability of CDR-H3 through steric effects","volume":"14","author":"Guloglu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675655","article-title":"Germline-dependent antibody paratope states and pairing specific VH-VL interface dynamics","volume":"12","author":"Fern\u00e1ndez-Quintero","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib60","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1038\/s41467-022-33764-1","article-title":"The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement","volume":"13","author":"Brinkhaus","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2024.07.014_bib61","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.2000732","article-title":"V Region of IgG controls the molecular properties of the binding site for neonatal Fc receptor","volume":"205","author":"Rossini","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.str.2024.07.014_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/19420862.2017.1389355","article-title":"Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics","volume":"10","author":"Piche-Nicholas","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143520","article-title":"Multi-angle effector function analysis of human monoclonal IgG glycovariants","volume":"10","author":"Dashivets","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2024.07.014_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009702","article-title":"Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya","volume":"15","author":"Ooms","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.str.2024.07.014_bib65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.it.2024.03.001","article-title":"Recombinant snake antivenoms get closer to the clinic","volume":"45","author":"Laustsen","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib66","series-title":"mouse models for drug discovery: Methods and\u00a0Protocols Methods in Molecular Biology","first-page":"103","article-title":"Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies","author":"Roopenian","year":"2016"},{"key":"10.1016\/j.str.2024.07.014_bib67","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/toxins12090528","article-title":"Novel snakebite therapeutics must be tested in appropriate rescue models to robustly assess their preclinical efficacy","volume":"12","author":"Knudsen","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.str.2024.07.014_bib68","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.tibtech.2021.03.003","article-title":"Animal immunization, in\u00a0vitro display technologies, and machine learning for antibody discovery","volume":"39","author":"Laustsen","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.str.2024.07.014_bib69","first-page":"13","article-title":"Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics","volume":"6","author":"Zhang","year":"2023","journal-title":"Antib. Ther."},{"key":"10.1016\/j.str.2024.07.014_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-6-46","article-title":"A simple vector system to improve performance and utilisation of recombinant antibodies","volume":"6","author":"Martin","year":"2006","journal-title":"BMC Biotechnology"},{"key":"10.1016\/j.str.2024.07.014_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2085536","article-title":"In\u00a0vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom","volume":"14","author":"Ledsgaard","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.str.2024.07.014_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/toxins10060236","article-title":"Basics of antibody phage display technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.str.2024.07.014_bib73","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In\u00a0vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2024.07.014_bib74","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.4049\/jimmunol.147.8.2657","article-title":"Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG","volume":"147","author":"Lund","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.str.2024.07.014_bib75","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.str.2024.07.014_bib76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2024.07.014_bib77","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.str.2024.07.014_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/ct401042b","article-title":"Constant pH replica exchange molecular dynamics in explicit solvent using discrete protonation states: implementation, testing, and validation","volume":"10","author":"Swails","year":"2014","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.str.2024.07.014_bib79","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1021\/jp303385x","article-title":"pH-Replica exchange molecular dynamics in proteins using a discrete protonation method","volume":"116","author":"Sabri Dashti","year":"2012","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.str.2024.07.014_bib80","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.str.2024.07.014_bib81","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.str.2024.07.014_bib82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57589","article-title":"On the importance of statistics in molecular simulations for thermodynamics, kinetics and simulation box size","volume":"9","author":"Gapsys","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.str.2024.07.014_bib83","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.str.2024.07.014_bib84","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/acs.jctc.3c01106","article-title":"The role of force fields and water models in protein folding and unfolding dynamics","volume":"20","author":"Fischer","year":"2024","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.str.2024.07.014_bib85","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1021\/acs.jcim.8b00462","article-title":"GPU-Accelerated molecular dynamics and free energy methods in Amber18: Performance enhancements and new features","volume":"58","author":"Lee","year":"2018","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.str.2024.07.014_bib86","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.str.2024.07.014_bib87","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.str.2024.07.014_bib88","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/acs.bioconjchem.2c00220","article-title":"Generation of multivalent nanobody-based proteins with improved neutralization of long \u03b1-neurotoxins from elapid snakes","volume":"33","author":"Wade","year":"2022","journal-title":"Bioconjugate Chem."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212624002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212624002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T15:09:17Z","timestamp":1727190557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212624002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0969212624002776"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2024.07.014","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2024.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}